Magnetic resonance imaging for myocardial viability

EuroIntervention

Volumn 6, Issue SUPPL. G, 2010, Pages

  Siebelink, Hans Marc J ^a   Lamb, Hildo J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiomyopathy; Magnetic resonance imaging; Revascularisation; Viability

Indexed keywords

DOBUTAMINE; GADOLINIUM CHELATE; CONTRAST MEDIUM; DIAGNOSTIC AGENT;

CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DIFFERENTIAL DIAGNOSIS; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE FIBROSIS; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE QUALITY; LOW DRUG DOSE; MYOCARDIAL HIBERNATION; MYOCARDIAL VIABILITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PROGNOSIS; QUANTITATIVE ANALYSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; STUNNED HEART MUSCLE; CONVALESCENCE; CORONARY ARTERY BLOOD FLOW; HEART DISEASE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; METHODOLOGY; MYOCARDIAL PERFUSION IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; TISSUE SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CONTRAST MEDIA; CORONARY CIRCULATION; DOBUTAMINE; HEART DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL PERFUSION IMAGING; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; TISSUE SURVIVAL; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 77957064994     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. European Coronary Surgery Study Group. Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. Lancet. 1982;2:1173-80.
2. Emond M, Mock MB, Davis KB, Fisher LD, Holmes DR Jr, Chaitman BR, Kaiser GC, Alderman E, Killip T 3rd. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90:2645-57.
3. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 1986;314:884-8. (Pubitemid 16126116)
4. Eitzman D, al-Aouar Z, Kanter HL, vom Dahl J, Kirsh M, Deeb GM, Schwaiger M. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol. 1992;20:559-65.
5. Di Carli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, Czernin J, Rokhsar S, Stevenson LW, Laks H, Hawkins R, Schelbert HR, Phelps ME, Maddahi J. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol. 1994;73:527-33. (Pubitemid 24142581)
6. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151-8. (Pubitemid 34267418)
7. McNamara MT, Tscholakoff D, Revel D, Soulen R, Schechtmann N, Botvinick E, Higgins CB. Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA. Radiology. 1986;158:765-9. (Pubitemid 16101273)
8. Kim HW, Farzaneh-Far A, Kim RJ. Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. J Am Coll Cardiol. 2009;55:1-16.
9. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992-2002. (Pubitemid 29529292)
10. Ibrahim T, Hackl T, Nekolla SG, Breuer M, Feldmair M, Schömig A, Schwaiger M. Acute myocardial infarction: serial cardiac MR imaging shows a decrease in delayed enhancement of the myocardium during the 1st week after reperfusion. Radiology. 2010;254:88-97.
11. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-53.
12. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, Blumenthal RS, Lima JA. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97:765-772. (Pubitemid 28135339)
13. Roes SD, Borleffs JW, van der Geest RJ, Westenberg JJM, Ajmone Marsan N, Kaandorp TAM, Reiber JHC, Zeppenfeld K, Lamb HJ, de Roos A, Schalij MJ, Bax JJ. Contrast-Enhanced MRI Predicts Spontaneous Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and Implantable Cardioverter-Defibrillator. Circ Cardiovasc Imaging. 2009;2:183-190.
14. Cheong BYC, Muthupillai R, Wilson JM, Sung A, Huber S, Amin S, Elayda MA, Lee VV, Flamm SD. Prognostic Significance of Delayed-Enhancement Magnetic Resonance Imaging Survival of 857 Patients With and Without Left Ventricular Dysfunction. Circulation. 2009;120:2069-2076.
15. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds G, Tsang S, Davis RB. Impact of Unrecognized Myocardial Scar Detected by Cardiac Magnetic Resonance Imaging on Event-Free Survival in Patients Presenting With Signs or Symptoms of Coronary Artery Disease. Circulation. 2006;113:2733-2743. (Pubitemid 43947991)
16. Vanoverschelde JL, D'Hondt AM, Marwick T, Gerber BL, De Kock M, Dion R, Wijns W, Melin JA. Head-to-head comparison of exercise- redistribution- reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol. 1996;28:432-42. (Pubitemid 26274340)
17. Wellnhofer E, Olariu A, Klein C, Gräfe M, Wahl A, Fleck E, Nagel E. Quantification for the Prediction of Functional Recovery Magnetic Resonance Low-Dose Dobutamine Test Is Superior to Scar. Circulation. 2004;109;2172-2174. (Pubitemid 38625392)
18. Bucciarelli-Ducci C, Lyne JC, Gatehouse PD, Pennell DJ. Cardiovascular magnetic resonance myocardial perfusion: methods and applications in patients with coronary artery disease. Heart. 2007 supplement autumn 4-11.
19. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. J Nucl Cardiol. 2002;9:240-5.
20. Ibrahim T, Bülow HP, Hackl T, Hörnke M, Nekolla SG, Breuer M, Schömig A, Schwaiger M. Diagnostic Value of Contrast-Enhanced Magnetic Resonance Imaging and Single-Photon Emission Computed Tomography for Detection of Myocardial Necrosis Early After Acute Myocardial Infarction. J Am Coll Cardiol. 2007;49:208-16. (Pubitemid 46054392)
21. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol. 1997;30:1451-60. (Pubitemid 27486461)
22. Kuhl HP, Beek AM, van der Weerdt AP, Hofman MBM, Visser CA, Lammertsma AA, Heussen N, Visser FC, van Rossum AC. Myocardial Viability in Chronic Ischemic Heart Disease.Comparison of Contrast- Enhanced Magnetic Resonance Imaging With 18F-Fluorodeoxyglucose Positron Emission Tomography. J Am Coll Cardiol. 2003;41:1341-8. (Pubitemid 36442708)
23. Selvanayagam JB, Porto I, Channon K, Petersen SE, Francis JM, Neubauer S, Banning AP. Troponin Elevation After Percutaneous Coronary Intervention Directly Represents the Extent of Irreversible Myocardial Injury. Insights From Cardiovascular Magnetic Resonance Imaging. Circulation. 2005;111:1027-1032.
24. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005;26:1461-74. (Pubitemid 41373486)